Obesity and type 2 diabetes mellitus

Diabetic Medicine

Volumn 17, Issue 5, 2000, Pages 400-402

  Wilding, J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PLACEBO; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; CASE REPORT; CLINICAL TRIAL; DIABETES CONTROL; DISEASE ASSOCIATION; DYSLIPIDEMIA; FECES INCONTINENCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; STEATORRHEA; WEIGHT REDUCTION;

EID: 0034039648     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00292-5.x     Document Type: Review

References (11)

1. 1 Lean, ME, Powrie, JK, Anderson, AS, Garthwaite, PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990 ; 7, 228 233.
2. 2 Wing, RR, Koeske, R, Epstein, LH, Nowalk, MP, Gooding, W, Becker, D. Long‐term effects of modest weight‐loss in type‐II diabetic‐ patients. Arch Intern Medicine 1987 ; 147, 1749 1753.
3. 3 Pories, WJ, Swanson, MS, MacDonald, KG, Long, SB, Morris, PG, Brown, BM. et al. Who would have thought it–an operation proves to be the most effective therapy for adult‐onset diabetes‐mellitus. Ann Surg 1995 ; 222, 339 352.
4. 4 Sjostrom, CD, Lissner, L, Wedel, H, Sjostrom, L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS Intervention Study. Obesity Res 1999 ; 7, 477 484.
5. 5 Sjostrom, L, Rissanen, A, Andersen, T, Boldrin, M, Golay, A, Koppeschaar, HP. et al. Weight loss and prevention of weight regain in obese patients: a 2‐year, European, randomised trial of orlistat. Lancet 1998 ; 352, 167 172.
6. 6 Davidson, MH, Hauptman, J, DiGirolamo, M, Foreyt, JP, Halsted, CH, Heber, D. et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat–a randomized controlled trial. JAMA 1999 ; 281, 235 242.
7. 7 Apfelbaum, M, Vague, P, Ziegler, O, Hanotin, C, Thomas, F, Leutenegger, E. Long‐term maintenance of weight loss after a very‐low‐calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Medicine 1999 ; 106, 179 184.
8. 8 Lean, MEJ. Sibutramine–a review of clinical efficacy. Int J Obesity 1997 ; 21, S30 S36.
9. 9 Hollander, PA, Elbein, SC, Hirsch, IB, Kelley, D, McGill, J, Taylor, T. et al. Role of orlistat in the treatment of obese patients with type 2 diabetes–a 1‐year randomized double‐blind study. Diabetes Care 1998 ; 21, 1288 1294.
10. 10 Griffiths, J, Finer, N, Bloom, SR, Jones, SP, Romanec, FM. Sibutramine in the treatment of non‐insulin dependent diabetics. Int J Obes 1995 ; 19, 41 (Abstract).
11. 11 Heath, MJ, Chong, E, Weinstein, SP, Seaton, TB. Sibutramine enhances weight loss and improves glycemic control and plasma lipid prole in obese patients with type 2 diabetes mellitus. Diabetes 1999 ; 48, 1346.